profit from every €100 of sales.
€0€100
Savencia SA
€56.80-1.05% today
-3.1% since Dec 23, 25
1-year low €54.401-year high €74.20
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay €9.80 for every €1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Savencia SA sold, what it kept, and what it did with the cash.
Sales went from €6.55 billion in 2022 to €6.96 billion in 2025, with €74.7 million of profit last year.
SalesProfit
Savencia SA handed back 46% of the cash it generated last year.
€28M
Free cash flow 2025€59M
Bought back its own shares–
Paid as dividends€28M
Cash vs. debt€526M vs. €1.2B
Savencia SA vs. similar companies
Savencia SA grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Savencia SA | 9.8× · Cheap | ||
 Nestlé | 25.0× · Fair price | ||
 Danone | 24.6× · Fair price | ||
 JBS | 19.8× · Fair price | ||
 Foshan Haitian Flavouring and Food | 29.0× · Fair price |
AI analysis
An AI analyst reads Savencia SA's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 6,551 | 6,791 | 7,140 | 6,957 | |
| 2,187 | 2,208 | 2,412 | 2,356 | |
| 163 | 169 | 204 | 162 | |
| 380 | 420 | 465 | 406 | |
| 68 | 96 | 107 | 75 | |
| 5.01 | 7.22 | 8.00 | 5.73 | |
| 33.4% | 32.5% | 33.8% | 33.9% | |
| 2.5% | 2.5% | 2.9% | 2.3% | |
| 1.0% | 1.4% | 1.5% | 1.1% |
Balance sheet
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 4,582 | 4,647 | 4,954 | 4,880 |
| Cash | 549 | 591 | 727 | 526 |
| Total debt | 1,078 | 1,185 | 1,209 | 1,238 |
| Total liabilities | 2,755 | 2,829 | 2,961 | 2,936 |
| 1,594 | 1,581 | 1,735 | 1,683 | |
| 14 | 13 | 13 | 13 | |
| 5.1% | 5.9% | 6.3% | 5.1% | |
| 4.3% | 6.1% | 6.2% | 4.4% |
Cash flow
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 255 | 261 | 387 | 314 | |
| 188 | 179 | 248 | 254 | |
| 67 | 82 | 139 | 59 | |
| Dividends paid | 27 | 24 | 22 | 28 |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 9.8×
- –
- 2.14
- 0.6×
- 0.1×
- 12.3×
- 3.6×
- 8.1%
- 10.2%
- 3.8%
Profitability
- 33.9%
- 2.3%
- 1.1%
- –
- 5.1%
- 5.6%
- –
- –
- –
- –
Growth
- +2.0%
- +4.6%
- –
- –
- −1.3%
Financial health
- 1.8×
- 0.74
- –
- 3.3×
- 1.12
- –
- –
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 18%of 669
Bottom 8%of 672
Top 15%of 623
Bottom 29%of 671
Top 29%of 666
3.8%of the share price, paid each year
On $1,000 invested$38a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
36.8% of its profit
Room to growStretchedMore than it earns: 46.3%
News
GLP-1s can save health system money if priced below $350 a month: analysisSeeking Alpha · Nov 14, 2026The 2027 401(k) limits are here. See how much more you can save next year.MarketWatch · Nov 14, 2026Can the Anthropic IPO Save the AI Rally?Yahoo Finance · Nov 14, 2026The iPhone Won’t Save AppleYahoo Finance · Nov 3, 2026Is that used EV worth the price? This checklist could save you thousands of dollars.MarketWatch · Oct 28, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
50No pass
Benjamin Graham
82Pass
Philip Fisher
42No pass
Peter Lynch
28No pass
Joel Greenblatt
50No pass
Charlie Munger
30No pass
Terry Smith
26No pass
Questions about Savencia SA
Is Savencia SA a good stock to buy?
A business with weak numbers, and the price looks low. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Savencia SA AI analysis
What does Savencia SA do?
Savencia SA produces, distributes, and markets dairy and cheese products in France, the Rest of Europe, and internationally. The company offers cheese, butter, creams, and dairy ingredients and nutritional solutions for the retail market and food services market. It is in Packaged Foods, based in Viroflay, France, with 22,680 employees.
Does Savencia SA pay a dividend?
Yes. At today's price the dividend is 3.8% a year, about 37% of its yearly profit. In 2025 it paid out €27.5 million in dividends.
Is Savencia SA stock halal?
No. Savencia SA does not pass our halal screen: its debt is 169% of its market value, at or above the 33% limit. How we check
Who are Savencia SA's competitors?
The largest listed companies in the same industry are Nestlé, Danone, JBS and Foshan Haitian Flavouring and Food. The peers table on this page compares their profit, growth and price with Savencia SA's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.